PET-CT Cost — Start With Whether You Need It
This is the one cost page on this site where the most useful advice is not about money at all. PET-CT is not a routine staging test for endometrial cancer. MRI answers the question that determines your operation — how deeply the tumour has invaded the uterine muscle — and CT or a chest X-ray covers whether disease is present elsewhere. For early-stage disease, adding PET-CT rarely changes the plan. So before asking what it costs, ask whether it is indicated. That is not a rationing argument; it is the same question your insurer will ask, and the reason requests without a stated indication are frequently declined.
- Not routine staging here — MRI is the workhorse for the pelvis
- Ask about indication first — it is the question that matters
- Insurers ask the same question — requests without one are often declined
- Genuinely indicated in specific situations — and worth having then
on Panel
Across India
Treated
(800+ reviews)
When It Is Genuinely Indicated
Five situations where PET-CT earns its cost. Outside these, the case weakens considerably.
| Situation | Why the scan is justified |
|---|---|
| Suspected recurrence | The strongest indication. Where a symptom, an examination finding or an equivocal scan raises the possibility of disease returning, PET-CT is well suited to finding where and to mapping how much. See detecting recurrence. |
| Before curative treatment of a recurrence | If salvage surgery or radiotherapy is being considered for what appears to be a single site, it matters enormously whether that is genuinely the only site. Exactly the question PET-CT answers well. See treating recurrence. |
| High-risk histological subtypes | Serous carcinoma, clear cell carcinoma and carcinosarcoma spread outside the pelvis more readily, so whole-body assessment before planning is more often justified. See serous carcinoma. |
| Suspicion of distant spread | Where symptoms, examination or another scan suggests disease outside the pelvis, PET-CT clarifies the extent in one study rather than a sequence of investigations. |
| Equivocal findings elsewhere | Where CT or MRI shows something that cannot be characterised and the answer would change your treatment. The test has to be capable of changing the plan to be worth its cost. |
Outside these situations — and particularly in early, low-grade disease confined to the uterus — PET-CT is generally not indicated. The reason is not cost. It rarely changes management and it carries a real chance of lighting up something benign such as inflammation, which then generates further scans, a possible biopsy, and a period of genuine fear. See PET-CT explained.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
What the Cost Covers
If the scan is indicated, this is what you are paying for.
- The radiotracer. A radioactive glucose analogue, produced in a facility with a limited shelf life, injected before the scan. A substantial component and the reason appointments cannot easily be rescheduled at short notice.
- Scanner and facility time. The appointment is long — there is a waiting period after the injection while the tracer distributes, during which you rest quietly, then the scan itself.
- Reporting. By a nuclear medicine physician or radiologist. Interpretation matters here more than for most scans, because benign uptake is common and distinguishing it requires experience.
- Diagnostic CT, if performed at the same sitting. Some protocols include a full contrast-enhanced CT alongside the PET. It adds information and it adds cost, so ask whether it is included and whether it is needed.
- Possible extras. Intravenous contrast, and provision of images in a portable format for a second opinion. Small items, occasionally billed separately, and worth asking about.
Want to Know Whether You Need This Scan?
Existing imaging reviewed by our tumour board before anything new is ordered or paid for.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Ask What Finding Would Change Your Treatment
If the answer is nothing, the scan is not worth its cost — at any price.
Questions Worth Asking First
Five that decide whether you should be paying for this at all.
"What would this scan change?"
The question that settles it. If a finding on PET-CT would alter your surgery, your radiotherapy or your systemic treatment, it is worth having. If the plan is the same either way, it is not — regardless of price. A good oncologist will answer this directly.
"Have I had the MRI and CT that come first?"
MRI is the standard test for local staging in endometrial cancer, and CT or a chest X-ray covers disease beyond the pelvis. PET-CT sits after those rather than instead of them. Being sent for PET-CT before an MRI is worth questioning. See MRI.
"Will my insurer or scheme cover it, and is authorisation done?"
Coverage generally requires a documented clinical indication and prior authorisation. Sort this before the scan, because seeking reimbursement afterwards for an unauthorised investigation frequently fails. See insurance and cover.
"Does this include a diagnostic CT?"
Some protocols include a full contrast-enhanced CT at the same sitting and some do not. It affects both the information obtained and the cost, so it is worth asking rather than discovering afterwards.
"Can I have the images to take away?"
Useful if you are seeking a second opinion, and it saves repeating the scan elsewhere — which is the most avoidable imaging cost of all. Ask for a copy on disc or a portable format at the time.
Unsure Whether the Scan Is Justified?
Bring your existing imaging. A review of what has been done and what would actually change the plan. The opinion is free.
Avoiding Money Spent for Nothing
Five practical points, and the first is the commonest waste in cancer imaging.
- Carry your images, not just your reports. The commonest avoidable imaging cost is a scan repeated at a second centre because the images were not available. A report is not a substitute; ask for the images on disc or in a portable format every time.
- Do not have a scan on your own initiative. Direct-access imaging bought without a clinical question produces findings nobody asked for and cannot easily interpret. It is a reliable route to unnecessary anxiety and further expense.
- Establish authorisation before the appointment. Not afterwards. This is where families most often lose money on imaging.
- Ask whether a cheaper test answers the question. Frequently CT, MRI or even a chest X-ray does. The right test is the one that answers your specific question, not the most comprehensive one available.
- Ask for the report to be explained. PET reports contain language — uptake, standardised values — that alarms people out of context. Having it explained is part of what you paid for. See PET-CT explained.
Why Scans Should Follow a Question
The right test is the one that answers your specific question — not the most comprehensive one available.
Tumour board for every diagnosis
Slides reviewed, not just the summary line
Costs explained before you commit
One place for the whole pathway
45-minute consultations
Second opinions welcomed, not resented
Take Your Images With You
A repeated scan because the images were not available is the most avoidable cost in cancer imaging.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.PET-CT Cost — Frequently Asked Questions
Do I need a PET-CT for endometrial cancer?
Often not. PET-CT is not a routine staging investigation for this disease. MRI is the standard test for local staging, because the question that most affects your operation — how deeply the tumour has invaded the muscle wall of the uterus — is one MRI answers well and PET-CT does not. CT or a chest X-ray covers whether disease is present outside the pelvis. In early-stage, low-grade disease, adding PET-CT seldom changes the plan, and it carries a real chance of lighting up something benign such as inflammation, which generates further tests and genuine fear. Ask what finding would change your treatment.
When is it genuinely worth the cost?
Most clearly when recurrence is suspected and needs locating, and when a recurrence appears confined to one site and salvage surgery or radiotherapy with curative intent is being considered — because whether that really is the only site changes everything. It is also more often justified in high-risk histological subtypes such as serous carcinoma, clear cell carcinoma and carcinosarcoma, which spread beyond the pelvis more readily; where symptoms or other imaging suggest distant disease; and where an equivocal finding elsewhere needs clarifying and the answer would alter management.
Why might my insurer refuse to cover it?
Because insurers and state health schemes generally require a documented clinical indication for PET-CT and decline requests that do not state one. That is worth knowing in advance for a practical reason: establish the indication and obtain pre-authorisation before the scan rather than seeking reimbursement afterwards, since claims for unauthorised investigations frequently fail. It is also a useful signal. If the scan is genuinely indicated, your oncologist can state why in a sentence — and that sentence is exactly what the insurer needs. If nobody can state it, notice that before paying privately.
What does the cost include?
The radiotracer, which is produced in a specialised facility and has a limited shelf life; scanner and facility time, including the waiting period after injection while the tracer distributes; technologist and nursing input; and reporting by a nuclear medicine physician or radiologist. Some protocols also include a full contrast-enhanced diagnostic CT at the same sitting, which adds both information and cost — ask whether it is included and whether it is needed. Intravenous contrast and provision of images in a portable format are occasionally billed separately.
How do I avoid paying for imaging twice?
Carry your images, not just your reports. A scan repeated at a second centre because the original images were unavailable is the commonest avoidable cost in cancer imaging, and a written report is not a substitute — a second opinion generally requires the images themselves. Ask for a copy on disc or in a portable format at the time of every scan and keep them with your reports. Beyond that: never arrange imaging on your own initiative without a clinical question, and always ask whether a cheaper test would answer the question equally well.
Medical disclaimer: This page explains when PET-CT is indicated in endometrial cancer and what a cost estimate covers. It is reviewed by a CION oncologist and deliberately does not publish price figures, because costs vary with centre, protocol and funding arrangement. Which imaging tests are appropriate depends on your tumour type, grade, apparent stage and clinical circumstances and should be decided by your treating team. Insurance and scheme coverage generally requires a documented indication and prior authorisation.